Leadership Team

Move at the Speed of Experience™ 


Christina J. Ansted, MPH, CCMEP

Co-Founder and CEO

Christina is a multifaceted biotech executive with expertise in global commercialization, medical communications and rare disease. Adept at building high-performance teams that drive value across an organization, Christina is deeply inspired to create a legacy of innovation by changing the approach to commercialization, improving rates of success and impacting the lives of patients worldwide.


Michael C. Janes

Co-Founder and CRO
Head, Private Market Practice

Michael has led global teams focused on global business development, private equity, sales operations, training and development, and business process optimization. With a commitment to outcomes and outstanding relationship management, Michael’s vision is to drive value creation for private market clients with biotech centric portfolios.


Daniel P. Silver, Esq.

Chief of Staff

Dan, an attorney by training, brings his legal expertise and experience as a biotech coordinator to support daily operations of the leadership team, executive corporate functions, vendor and partner relations and strategic implementation.

Greg Fuest

Greg Fuest

Chief Commercial & Strategy Officer

Greg is an exceptional marketing and commercial strategy executive with extensive experience in large pharma and startup biotechs leading cross-functional teams for pre-launch, launch, re-launch and in-market brands in primary care, oncology, virology, respiratory, gene therapy and rare disease both globally and in the U.S., in addition to divisional/regional sales management expertise.


Edward Dow, MD

Chief Medical Officer

Edward is a highly experienced physician executive and practicing Hematologist-Oncologist with extensive expertise in global medical affairs and clinical development providing data generation and synthesis for medical support of new product commercialization. Ed continues to see patients with cancer and blood diseases on a part-time basis.


Paresh Soni, MD, PhD

SVP, Clinical and Corporate Development

Paresh is a board-certified internist and gastroenterologist with broad medical/scientific and corporate management  experience having led global multidisciplinary teams across the development spectrum – from translational medicine to successful approval.


Barry Marston

SVP, MedTech Ventures

Barry is a senior level medical device executive with demonstrated leadership in sales and marketing strategy, business and product development, strategic analysis and growth planning and oversees all RCP medical device engagements.


Steve M. Palmisano, ISMPP CMPP

SVP, Medical and Scientific Communications

Steve is a seasoned healthcare communications executive known for innovative and alternative approaches. A strategic thinker, Steve leverages his operational and technology expertise to improve work efficiency and notably was the creator of the pharma industry’s 1st scientific communications platform and now industry standard.


Kevin W. Mayo, PhD, EJD

VP, Global Market Access and Health Economics

Kevin’s extensive expertise in market access, pricing and reimbursement, HEOR, health policy and government affairs, and patient /medical advocacy enables him to maximize global revenue potential and market share growth. He leads patient and market access strategy and implementation.


Jennifer King, MBA

VP, Global Pricing and Payer Insights

Jennifer brings a wealth of commercial and market access experience across oncology and orphan drugs. She is well-versed in global, EMEA and Asia Pacific/Japan markets supporting pricing and market access strategies in both strategic development and implementation with the goal of achieving optimal access for all stakeholders.


Joseph Rubino

SD, Reimbursement and Market Access Strategy

Joseph is a veteran market access, reimbursement and government affairs expert with interests in diagnostic and medical device strategy, HEOR and payer/provider market research. He leads projects focused on coding, coverage, payment, evidence generation, launch plans and value communication strategies.


Tom Lo, MS, MBA

Head, Clinical Science and Diagnostic Strategy

Tom has exceptional experience expanding the treatable patient population for therapeutics. With a focus on building awareness for diagnostic testing to enable optimal patient identification and timely therapy, Tom has led diagnostic strategy for eight rare diseases and provided leadership to develop and implement diagnostic strategy supporting field implementation and training across a myriad of therapeutic areas. He applies his considerable field sales acumen to ensure successful collaboration, integration, and execution of strategic diagnostic initiatives.